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Abstract
Background: The relative frequency of acute intracranial large vessel occlusion (LVO) in patients with acute ischemic
stroke (AIS) who could be candidate for intra-arterial treatment (IAT) is not well known. In this study, we determined
clinical variables associated with LVO and the proportion of patients with LVO among patients presenting with AIS
within 6 h of symptom onset.
Methods: Data of consecutive patients with AIS presenting at the emergency department (ED) of the Erasmus
University Medical Center, in the Netherlands, was used. Referrals from other hospitals were excluded.
Results: From 2006 January 1st to 2012 April 30th, 1063 non-referred patients presented at our ED with AIS. 445 (42 %)
arrived within 6 h of onset of symptoms. Computed tomography angiography was not performed or was of
insufficient quality in 50 patients (11 %) and performed late (≥1 day) in 57 patients (13 %). The remaining 338 with AIS
were included in the final analysis. 106 patients (31 %) had LVO, mostly in the anterior circulation (72 %). National
Institutes of Health Stroke Scale score was the only variable associated with the presence of LVO (adjusted OR 1.23 per
point [95 % Confidence interval: 1.17–1.29]).
Conclusion: Of all patients with acute ischemic stroke who arrive within 6 h of symptom onset at the
emergency department, almost one out of three have a intracranial large vessel occlusion and may be
candidate for intra-arterial treatment.
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Background
Recently published randomized clinical trials showed that
intra-arterial treatment (IAT) with retrievable stents for
acute ischemic stroke (AIS) was safe and effective in pa-
tients with acute intracranial large vessel occlusion (LVO)
if they were treated within 6 h of symptom onset [1–6].
Updated guidelines indicate that IAT is now standard of
care for AIS patients with LVO [7, 8]. This has great im-
pact on stroke care providers, as the number of performed
procedures increases rapidly and resources are limited. To
estimate the number of candidates for IAT, it is important
to know how many patients with AIS present with LVO.
Observational studies report that 10–61 % of the pa-
tients who present at the emergency department (ED)
with presumed AIS have LVO. However, these studies did
not include unselected, consecutive patients [9], did not
use appropriate neuro-imaging in all patients [10], in-
cluded patients who were transferred from other hospitals
[11, 12], or used a restricted time window [13].
Knowledge of the occurrence of LVO is important
clinically, for manpower planning and for resource allo-
cation. In this study we describe the occurrence of LVO
cases in a consecutive population of all AIS patients
admitted to emergency department (ED) within 6 h after




This retrospective single center study of a consecutive
patient cohort was executed by the Erasmus University
Medical Center, Rotterdam, the Netherlands. The patient
population represents an urban population in a large
city, where stroke patients are referred from general
practitioners and other centers. Patients with AIS were
identified from our Erasmus Stroke Registry, which is
operational since 1990. All patients admitted to the ED
with a presumed diagnosis of acute stroke are seen by a
neurologist or a resident in neurology as part of clinical
routine. Patients with AIS were entered into the registry
after review and confirmation of the diagnosis by a vas-
cular neurologist. For the present study electronical
medical charts and imaging were used. No additional
data collection was performed and institutional review
board was not needed. All non-referral patients with
AIS in the period of From 2006 January 1st to 2012
April 30th who were admitted to the ED were included.
Patients had to be 18 years or older. Patients arriving
later than 6 h after onset of symptoms at the emergency
department were excluded. Patients who did not re-
ceive a Computed Tomography Angiography (CTA) or
in whom the CTA was of insufficient quality, and patients
in whom a CTA was made more than 24 h after intraven-
ous alteplase treatment (IVT) or more than 48 h after
stroke onset were also excluded from the present study.
Magnetic resonance imaging was never used instead of
CTA.
Clinical variables
We determined the clinical location of the occlusion by
categorizing symptoms, described by the attending neur-
ologist or resident in neurology in the medical chart, as
belonging to occlusion in the territory of the right or left
carotid artery or the vertebrobasilar arteries. Further-
more, the National Institutes of Health Stroke Scale
(NIHSS) on admission and time from onset of symptoms
to arrival at the ED were assessed. Data on medical his-
tory were collected from medical records of the patients.
The diagnosis of atrial fibrillation (AF) could be based
on pre-existing AF, identified through medical history
and de novo AF during hospitalization. All patients were
monitored during the first 24 h after AIS and the diag-
nosis of de novo AF was confirmed by 12-lead ECG. The
diagnosis of previous stroke was based on history, transi-
ent ischemic attack was not included.
CTA acquisition and analysis
CTA was performed with a 16-slice multidetector CT
(MDCT) scanner (Siemens, Sensation 16, Erlangen,
Germany), a 64-slice MDCT scanner (Siemens, Sensa-
tion 64, Erlangen, Germany) or a 128 slice MDCT scan-
ner (Siemens, Definition AS, Erlangen, Germany) with a
standardized optimized contrast-enhanced protocol
(100–120 kVp, collimation 16×0.75 mm, 64×0.6 mm, or
128×0.6 mm, pitch ≤1) [14, 15]. The CTA scan ranged
from the ascending aorta to the intracranial circulation.
Contrast material was given in a bolus of 80 ml (Iodixa-
nol 320 mg/ml, Visipaque, Amersham Health, Little
Chalfont, UK), followed by a 40 ml saline bolus chaser.
The injection rate was 4 ml/s for both Iodixanol and sa-
line. At the level of the ascending aorta contrast material
passage was detected by real time bolus tracking
followed by data acquisition. The images were recon-
structed by a 100 mm field of view, matrix size 512×512
(real in-plane resolution 0.6x0.6 mm), slice thickness
≤1.0 mm, increment ≤0.6 mm and with an intermediate
reconstruction algorithm.
CTA images were sent to a stand-alone workstation
(Leonardo, Siemens Medical Solutions, Forchheim,
Germany) with dedicated 3D analysis software, and were
assessed by experts (GS, PH, AL) who had no clinical
information other than a clinical diagnosis of AIS. Of all
CTAs the extracranial and intracranial circulation were
evaluated blinded without knowledge of the clinical data
with multiplanar reformatting software, which allows
also reconstruction of sagittal, coronal, and oblique max-
imum intensity projections from axial sections.
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The location of LVO was categorized as: intracranial in-
ternal carotid artery (ICA), anterior cerebral artery (A1
segment), proximal middle cerebral artery (M1 segment),
distal middle cerebral artery (M2 segment), intracranial
vertebral artery (IVA), basilar artery (BA), proximal
posterior cerebral artery (P1 segment), distal posterior
cerebral artery (P2 segment). Patients suffering from
occlusions in multiple segments were categorized by their
most proximal intracranial occlusion at the level of the
circle of Willis. In addition, occlusions in the extracranial
carotid artery and vertebral artery were assessed.
Outcome
LVO was defined as an occlusion in one of the intracranial
arteries (ICA, A1, M1, M2, IVA, BA, P1 and P2), accom-
panied by clinical symptoms that could be attributed to
ischemia in the territory of the occluded artery.
Statistical analysis
We used cross tabulation, univariable and multivariable
logistic regression analysis. We expressed associations as
odds ratios with 95 % confidence intervals (CIs). Statis-
tical analyses were performed with Stata/SE 14.1 (Stata-
Corp. Texas. USA). We considered NIHSS, previous
ischemic stroke and AF as possible predictors of occlu-
sion, and we adjusted for age, gender and time to ED.
Results
Over a 6-year period 1063 patients with AIS were admit-
ted to our ED. Of these 1063 patients, 618 (53 %) were ex-
cluded because they arrived more than 6 h after onset of
symptoms at the emergency department (Fig. 1).
Of the 445 patients who presented within 6 h after
onset of symptoms CTA was not performed or of in-
sufficient quality in 50 patients (11 %), and CTA was
performed ≥ 24 h after IVT or ≥48 h after stroke onset
in 57 patients (13 %) (Fig. 1). Most of these 107 pa-
tients with no or late CTA were admitted in the early
phase after implementation of acute CTA in AIS pa-
tients (2006–2008). Clinical characteristics, including
NIHSS at baseline in these 107 patients (median = 5;
IQR:2–12) were similar to the total 338 patients (median
= 5; IQR:2–11) with CTA in the acute phase (p = 0.67). Of
the remaining 338 patients with clinical symptoms of AIS,
106 patients (31 %) had LVO. These patients had a mean
age of 64 ± 15 years and 53 patients (50 %) were male
(Table 1). The median NIHSS on admission was 13 (6–
18). Of these, 77 patients (73 %) had an occlusion in the
anterior circulation and 29 patients (27 %) had an occlu-
sion in the posterior circulation (Table 2).
Clinical predictors of LVO
Only admission NIHSS was associated with LVO
(adjusted Odds Ratio (aOR) = 1.23 per NIHSS point
increase [95 % CI: 1.17–1.29]) (Table 1). Patients
with NIHSS of 1 or 2 had a 10 % likelihood of LVO
(Fig. 2). A score of exactly 12 points on NIHSS indi-
cates a likelihood of 50 % for LVO. When NIHSS ≥
12, likelihood of LVO is 75 %. NIHSS of 7 and
above corresponds with a > 50 % likelihood of LVO.
When NIHSS ≥ 20, 21 (91 %) of 23 patients had
LVO. Of the two patients with NIHSS ≥ 20 without
LVO, one had had a previous stroke, with conse-
quently a pre-stroke modified Rankin Scale score of
3 with a spastic hemiparesis; new stroke symptoms
Fig. 1 Inclusion chart of the patients. ED = emergency department, CTA = computer tomography angiography, AIS = acute ischemic stroke
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were aphasia and facial palsy. The other patient who
had a NIHSS score of 22, experienced rapid recovery
without IVT. No association was found between the
presence of LVO and AF (aOR = 1.10 [95 % CI:
0.43–2.79]) or previous ischemic stroke (aOR = 0.69
[95 % CI: 0.34–1.44]) (Table 1).
Discussion
This study of an unselected non-referred consecutive
cohort of AIS patients arriving at the ED within 6 h of
symptom onset, showed that almost one out of three
have LVO and may be IAT candidate.
Clinical practice
Our study suggests that almost one third of all pa-
tients with AIS may be candidates for IAT, since they
had LVO in the proximal anterior or posterior circu-
lation and these LVO locations are currently treated
in clinical practice in the Netherlands and registered
in the MR CLEAN Registry (www.mrclean-trial.org).
This is in concordance with data from Copenhagen
where 29 % had LVO. The population in the latter
study was different from ours, since only IVT candi-
dates were studied, which implies a restricted time
window and extra criteria for candidates in compari-
son to IAT candidates [13]. However, both these esti-
mates are based on a consecutive AIS population
presenting at EDs. In two large and well documented
studies from Bern, using an overlapping population,
40–61 % of patients had LVO [12]. However, these
studies included patients who were referred from
other centers, which implies selection and at least
partly explains the higher proportion of patients with
LVO. This makes it difficult to extrapolate these esti-
mates to other settings.
Our results confirm that NIHSS score at baseline is
the most important predictor of LVO, as reported
previously [12, 13, 16]. We found that a vast majority
(91 %) of patients with NIHSS ≥ 20 had LVO. This high
percentage of occlusion in patients with severe clinical
Table 1 Baseline characteristics of the study population with






Age (years), mean (SD) 64 (15) 62 (16) 0.26
Male sex, n (%) 53 (50 %) 116 (50 %) 1.00
Caucasian ethnicity, n (%) 81 (76 %) 184 (79 %) 0.55
Systolic blood pressure, mean (SD) 161 (38) 167 (33) 0.16
Diastolic blood pressure, mean (SD) 85 (21) 89 (19) 0.11
BMI (kg/m2), mean (SD) 28 (3.8) 27 (5.1) 0.50
Glucose (mmol/L), mean (SD) 7.6 (2.4) 7.3 (2.8) 0.33
Previous ischemic stroke, n (%) 18 (17 %) 52 (23 %) 0.22
Previous heart disease, n (%) 14 (13 %) 41 (18 %) 0.28
Atrial fibrillation, n (%) 14 (13 %) 19 (8 %) 0.16
NIHSS on admission, median (IQR) 13 (6-18) 3 (2–7) <0.01
All patients arrived at the emergency department within 6 h after onset of
symptoms and received a CT-angiography of the intracranial circle of Willis in
the acute phase. NIHSS on admission significantly differed between
both groups
BMI body mass index, NIHSS National Institutes of Health Stroke Scale. NIHSS
on admission significantly differed between both groups
Table 2 Distribution and location of acute intracranial large
vessel occlusion (LVO)
Anatomical location LVO Number and percentage of
total LVO (n = 106)
Anterior circulation (n = 77)
Anterior cerebral artery,
A1 segment, n (%)
0
Intracranial carotid artery, n (%) 23 (22 %)
Middle cerebral artery,
M1 segment, n (%)
38 (36 %)
Middle cerebral artery,
M2 segment, n (%)
16 (15 %)
Posterior circulation (n = 29)
Intracranial vertebral artery, n (%) 9 (9 %)
Posterior cerebral artery,
P1 segment, n (%)
8 (8 %)
Posterior cerebral artery,
P2 segment, n (%)
3 (2 %)
Basilar artery, n (%) 9 (9 %)
A1 first segment of anterior cerebral artery, M1 first segment of middle
cerebral artery, M2 second segment of middle cerebral artery, P1 first
segment of posterior cerebral artery, P2 second segment of the posterior
cerebral artery
Fig. 2 The association between National Institutes of Health Stroke
Scale (NIHSS) and the likelihood of the presence of acute intracranial
large vessel occlusion (LVO) confirmed by CTA, in 338 patients with
acute ischemic stroke, admitted within 6 h of symptom onset. For
each point increase in NIHSS, aOR is 1.23 (95 % CI: 1.17-1.29) for
having LVO. At NIHSS 12 the chance of having LVO is 0.5 (50 %)
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symptoms is in concordance with other studies, where
more than 95 % of patients with NIHSS ≥ 20 had an
occlusion [12, 13]. However, our study also emphasizes
that patients with low NIHSS could have LVO.
Limitations
Several limitations may influence the generalizability
of our study results. First, our study was a single center
study in an academic hospital. However, our center is a
centrally located comprehensive stroke center and it
has no restrictions on access to the ED. We present a
consecutive series of non-referred patients, which we
believe is representative for any urban population in a
large city like Rotterdam. Second, 107 patients (24 %)
who presented at the ED within 6 h after symptom
onset did not get a CTA in the acute phase. Most of
these patients were admitted to our hospital in the first
years after implementation of acute CTA in AIS
patients, in 2006. In that early period CTA was some-
times performed later or not at all, despite being part
of standard protocol. Most importantly there was no
selection bias based on stroke severity as there was no
difference in baseline NIHSS between the patients with
and without CTA. Since NIHSS at baseline is the most
important predictor of LVO, there is no reason to
assume that the rate of LVO in these patients differs
from in those who had CTA in the acute phase and
were included in our analysis.
Conclusion
Of all patients with acute ischemic stroke who arrive
within 6 h of symptom onset at the emergency
department, almost one out of three will have an
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